Loading...
Founded in 2019
Cognigenics is leveraging the power of CRISPR to enhance human cognitive performance. Our technology is broadly applicable to a wide spectrum of cognitive issues which affect 80 million Americans including stress, anxiety and depression.
Founded
2019
Employees
Funding
Ted Moskovitz
Advisor
David Langer
Investor